NCT05741164 2026-02-17
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
Emory University
Phase 2 Not yet recruiting
Clinical Trials
5 trialsNCT02013492 2022-12-06
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT01847001 2021-09-10
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Columbia University
Phase 2 Completed
NCT02596867 2018-03-01
NPBC
Texas Tech University Health Sciences Center, El Paso
Phase 2 Terminated
NCT00502684 2014-07-01
Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery
Kaplan Medical Center
Phase NA Unknown